20 years of Cure Parkinson's
We’re here for the cure! This year marks 20 years since Cure Parkinson’s was founded by four people living with Parkinson’s who felt that nobody was taking a cure seriously enough and that there was an urgent need for a focused approach to curative research...
Learn more
Parkinson’s drug therapies in the clinical trial pipeline: 2023 update
Cure Parkinson’s has collaborated annually with Parkinson’s advocates and the Michael J Fox Foundation to present an update on the clinical trials landscape for Parkinson’s. The 2023 report is now published.
Phase 2 UDCA in Parkinson’s trial results published
Cure Parkinson’s is excited to announce that the results from the ‘UP Study’ – a phase 2 study of the liver drug UDCA in Parkinson’s – will be published in the academic journal Movement Disorders.
2025 Yorkshire Marathon
Dust off your trainers and take part in the jewel in White Rose County’s sporting events crown in support of Cure Parkinson’s! Since the inaugural event in 2013, the Yorkshire Marathon has gotten bigger and bigger. Every year, thousands of runners of all abilities take...
Cure Parkinson’s CEO discusses hope for a cure with the Movers & Shakers
The latest episode of the hugely popular Movers & Shakers podcast features our very own Will Cook, CEO of Cure Parkinson’s. This episode, which also features University College London’s Professor Tom Foltynie, looks at the progress of ongoing clinical work in the world of Parkinson’s research…
Our 2023 research impact report
Our recent research impact report determines and highlights the impact our research funding has had on the Parkinson’s research field.